JPH11505255A5 - - Google Patents

Info

Publication number
JPH11505255A5
JPH11505255A5 JP1996535063A JP53506396A JPH11505255A5 JP H11505255 A5 JPH11505255 A5 JP H11505255A5 JP 1996535063 A JP1996535063 A JP 1996535063A JP 53506396 A JP53506396 A JP 53506396A JP H11505255 A5 JPH11505255 A5 JP H11505255A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
JP1996535063A
Other languages
English (en)
Japanese (ja)
Other versions
JPH11505255A (ja
Filing date
Publication date
Priority claimed from US08/444,567 external-priority patent/US5726184A/en
Application filed filed Critical
Publication of JPH11505255A publication Critical patent/JPH11505255A/ja
Publication of JPH11505255A5 publication Critical patent/JPH11505255A5/ja
Ceased legal-status Critical Current

Links

JP8535063A 1995-05-19 1996-05-16 Mdr活性を有するテトラリン化合物 Ceased JPH11505255A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US08/444,567 US5726184A (en) 1995-05-19 1995-05-19 Tetralin compounds with improved MDR activity
US08/444,567 1995-05-19
PCT/US1996/007094 WO1996036630A1 (en) 1995-05-19 1996-05-16 Tetralin compounds with mdr activity

Publications (2)

Publication Number Publication Date
JPH11505255A JPH11505255A (ja) 1999-05-18
JPH11505255A5 true JPH11505255A5 (enExample) 2004-07-08

Family

ID=23765456

Family Applications (1)

Application Number Title Priority Date Filing Date
JP8535063A Ceased JPH11505255A (ja) 1995-05-19 1996-05-16 Mdr活性を有するテトラリン化合物

Country Status (22)

Country Link
US (1) US5726184A (enExample)
EP (1) EP0839143B1 (enExample)
JP (1) JPH11505255A (enExample)
KR (1) KR19990014848A (enExample)
CN (1) CN1184475A (enExample)
AT (1) ATE221881T1 (enExample)
AU (1) AU705167B2 (enExample)
BR (1) BR9608789A (enExample)
CA (1) CA2219752A1 (enExample)
CZ (1) CZ364197A3 (enExample)
DE (1) DE69622871T2 (enExample)
DK (1) DK0839143T3 (enExample)
ES (1) ES2179945T3 (enExample)
HU (1) HUP9802679A3 (enExample)
IL (1) IL118269A0 (enExample)
NO (1) NO975198L (enExample)
NZ (1) NZ308789A (enExample)
PL (1) PL323490A1 (enExample)
PT (1) PT839143E (enExample)
SK (1) SK155497A3 (enExample)
WO (1) WO1996036630A1 (enExample)
ZA (1) ZA963959B (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5798355A (en) * 1995-06-07 1998-08-25 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity
US5696135A (en) 1995-06-07 1997-12-09 Gpi Nil Holdings, Inc. Inhibitors of rotamase enzyme activity effective at stimulating neuronal growth
US5859031A (en) * 1995-06-07 1999-01-12 Gpi Nil Holdings, Inc. Small molecule inhibitors of rotamase enzyme activity
US5780484A (en) * 1996-11-13 1998-07-14 Vertex Pharmaceuticals Incorporated Methods for stimulating neurite growth with piperidine compounds
US5811434A (en) * 1996-11-13 1998-09-22 Vertex Pharmacueticals Incorporated Methods and compositions for stimulating neurite growth
EP0959882A4 (en) * 1996-12-31 2001-12-05 N-LINKED UREAS AND CARBAMATES OF HETEROCYCLIC THIOESTERS
US5935989A (en) 1996-12-31 1999-08-10 Gpi Nil Holdings Inc. N-linked ureas and carbamates of heterocyclic thioesters
US5846979A (en) 1997-02-28 1998-12-08 Gpi Nil Holdings, Inc. N-oxides of heterocyclic esters, amides, thioesters, and ketones
US20010049381A1 (en) 1997-06-04 2001-12-06 Gpl Nil Holdings, Inc., Pyrrolidine derivative hair growth compositions and uses
US5945441A (en) 1997-06-04 1999-08-31 Gpi Nil Holdings, Inc. Pyrrolidine carboxylate hair revitalizing agents
US6331537B1 (en) 1998-06-03 2001-12-18 Gpi Nil Holdings, Inc. Carboxylic acids and carboxylic acid isosteres of N-heterocyclic compounds
FR2781218B1 (fr) * 1998-07-15 2001-09-07 Lafon Labor Compositions pharmaceutiques comprenant des 2-quinolones
US6337340B1 (en) 1998-08-14 2002-01-08 Gpi Nil Holdings, Inc. Carboxylic acids and isosteres of heterocyclic ring compounds having multiple heteroatoms for vision and memory disorders
US6218423B1 (en) 1998-08-14 2001-04-17 Gpi Nil Holdings, Inc. Pyrrolidine derivatives for vision and memory disorders
US6395758B1 (en) 1998-08-14 2002-05-28 Gpi Nil Holdings, Inc. Small molecule carbamates or ureas for vision and memory disorders
US7338976B1 (en) 1998-08-14 2008-03-04 Gpi Nil Holdings, Inc. Heterocyclic esters or amides for vision and memory disorders
US6462072B1 (en) 1998-09-21 2002-10-08 Gpi Nil Holdings, Inc. Cyclic ester or amide derivatives
US6300341B1 (en) 1998-09-30 2001-10-09 The Procter & Gamble Co. 2-substituted heterocyclic sulfonamides
US6307049B1 (en) 1998-09-30 2001-10-23 The Procter & Gamble Co. Heterocyclic 2-substituted ketoamides
AU5606400A (en) 1999-07-09 2001-01-30 Ortho-Mcneil Pharmaceutical, Inc. Neurotrophic tetrahydroisoquinolines and tetrahydrothienopyridines, and related compositions and methods
FR2797444B1 (fr) * 1999-08-13 2003-02-07 Lafon Labor Compositions pharmaceutiques comprenant des 4-quinolones
HUP0303719A2 (hu) * 2000-10-16 2004-03-01 Neopharm, Inc. Mitoxantron hatóanyag-tartalmú liposzómás gyógyszerkészítmények és eljárás az előállításukra
US6693099B2 (en) 2000-10-17 2004-02-17 The Procter & Gamble Company Substituted piperazine compounds optionally containing a quinolyl moiety for treating multidrug resistance
US6376514B1 (en) * 2000-10-17 2002-04-23 The Procter & Gamble Co. Substituted six-membered heterocyclic compounds useful for treating multidrug resistance and compositions and methods thereof
US20030203890A1 (en) * 2001-05-29 2003-10-30 Steiner Joseph P. Method for treating nerve injury caused as a result of surgery
BR0213989A (pt) * 2001-11-07 2005-03-01 Pharmacia Corp Métodos para promover a absorção e acúmulo nuclear de poliamidas em células eucarióticas
WO2005007162A1 (en) * 2003-07-10 2005-01-27 Vertex Pharmaceuticals Incorporated Compounds augmenting the activity of antibacterial agents
US20080221163A1 (en) * 2005-01-18 2008-09-11 Jeffrey Alan Dodge Selective Estrogen Receptor Modulators
CN102655865A (zh) 2009-09-11 2012-09-05 沃泰克斯药物股份有限公司 N-苄基-3-(4-氯苯基)-2-[甲基-[2-氧代-2-(3,4,5-三甲氧基苯基)乙酰基]氨基]-n-[3-(4-吡啶基)-1-[2-(4-吡啶基)乙基]丙酰胺的组合物及其用途
CN103130631A (zh) * 2011-11-29 2013-06-05 中国人民解放军第二军医大学 1-取代苯亚甲基-2-萘酮类衍生物及制备方法和用途

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5192773A (en) * 1990-07-02 1993-03-09 Vertex Pharmaceuticals, Inc. Immunosuppressive compounds
NZ314207A (en) * 1992-09-28 2000-12-22 Vertex Pharma 1-(2-Oxoacetyl)-piperidine-2-carboxylic acid derivatives as multi drug resistant cancer cell sensitizers
US5387685A (en) * 1993-07-16 1995-02-07 American Cyanamid Co MDR reversal agents

Similar Documents

Publication Publication Date Title
JP2000500033A5 (enExample)
JP2000500228A5 (enExample)
JP2000500445A5 (enExample)
JPH11510837A5 (enExample)
JP2000500440A5 (enExample)
JPH11512303A5 (enExample)
JPH11510779A5 (enExample)
JP2000500145A5 (enExample)
JP2000500155A5 (enExample)
JP2000500406A5 (enExample)
JP2000501200A5 (enExample)
JP2000500115A5 (enExample)
JP2000500192A5 (enExample)
JP2000507301A5 (enExample)
JP2000500112A5 (enExample)
JPH11510141A5 (enExample)
JP2000501753A5 (enExample)
JP2000500226A5 (enExample)
JP2000500051A5 (enExample)
JP2000500397A5 (enExample)
JP2000500407A5 (enExample)
JP2000500019A5 (enExample)
JP2000500166A5 (enExample)
JP2000500125A5 (enExample)
JP2000500044A5 (enExample)